Organogenesis Holdings (ORGO) Free Cash Flow (2016 - 2026)

Organogenesis Holdings' Free Cash Flow history runs 11 years deep, the most recent figure standing at $18.0 million for Q1 2026.

• In Q1 2026, Free Cash Flow rose 176.32% year-over-year to $18.0 million; the TTM figure through Mar 2026 stood at $17.1 million (up 302.47% YoY), while the FY2025 annual figure was -$24.5 million, down 685.73% from the prior year.
• Free Cash Flow was $18.0 million for Q1 2026 at Organogenesis Holdings, down from $34.8 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $34.8 million in Q4 2025 to a low of -$36.5 million in Q2 2025.
• Historically, Free Cash Flow has averaged -$281705.9 across 5 years, with a median of -$458000.0 in 2022.
• The sharpest annual moves came in 2023 and 2025: Free Cash Flow surged 1946.13% in 2023, then tumbled 2667.58% in 2025.
• A 5-year view of Free Cash Flow shows it stood at -$2.9 million in 2022, then surged by 355.25% to $7.3 million in 2023, then climbed by 3.92% to $7.6 million in 2024, then surged by 358.92% to $34.8 million in 2025, then plunged by 48.28% to $18.0 million in 2026.
• The last three Free Cash Flow figures came in at $18.0 million (Q1 2026), $34.8 million (Q4 2025), and $844000.0 (Q3 2025), per Business Quant data.